Furthermore, GWAS can miss yet-to-be-identified novel variants (e.g. in Asians) not incorporated into existing genotyping arrays (18), as exemplified by the recent identification of DOCK2 (dedicator of cytokinesis 2) in the Japanese COVID-19 cohort (11). The gene discussed is DOCK2; the disease is COVID-19.